Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Znf_C2H2	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF831 ZFR2 ZNF479 ZNF841 ZNF598 ZNF577 ZNF628 ZNF473 TUT7 E4F1 PRDM5 ZNF365 ZNF786 ZFPM2 HIVEP3 ZNF106 ZNF592 ZNF41 ZNF540 ZNF804B ZNF726 ZNF646	2.77e-08	805	197	28	IPR007087
Domain	Znf_C2H2-like	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF831 ZFR2 ZNF479 ZNF841 ZNF598 ZNF577 ZNF628 ZNF473 E4F1 PRDM5 ZNF365 ZNF786 ZFPM2 HIVEP3 ZNF106 ZNF592 ZNF41 ZNF540 ZNF804B ZNF726 ZNF646	8.39e-08	796	197	27	IPR015880
Domain	ZnF_C2H2	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF831 ZFR2 ZNF479 ZNF841 ZNF598 ZNF577 ZNF628 ZNF473 E4F1 PRDM5 ZNF365 ZNF786 ZFPM2 HIVEP3 ZNF106 ZNF592 ZNF41 ZNF540 ZNF804B ZNF726 ZNF646	1.13e-07	808	197	27	SM00355
Domain	ZINC_FINGER_C2H2_1	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF831 ZNF479 ZNF841 ZNF598 ZNF577 ZNF628 ZNF473 TUT7 E4F1 PRDM5 ZNF786 ZFPM2 HIVEP3 ZNF106 ZNF592 ZNF41 ZNF540 ZNF804B ZNF726 ZNF646	1.94e-07	777	197	26	PS00028
Domain	ZINC_FINGER_C2H2_2	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF831 ZNF479 ZNF841 ZNF598 ZNF577 ZNF628 ZNF473 E4F1 PRDM5 ZNF786 ZFPM2 HIVEP3 ZNF106 ZNF592 ZNF41 ZNF540 ZNF804B ZNF726 ZNF646	6.72e-07	775	197	25	PS50157
Domain	ARM-type_fold	CKAP5 TEX10 RYR3 DOCK5 PSME4 PIK3CG UTP20 KPNA5 XPO4 APOB ODAD2 MROH8 CNOT9 LTN1 INTS4	3.30e-06	339	197	15	IPR016024
Domain	zf-C2H2	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF479 ZNF841 ZNF577 ZNF628 ZNF473 E4F1 PRDM5 ZNF786 ZFPM2 HIVEP3 ZNF106 ZNF592 ZNF41 ZNF540 ZNF726 ZNF646	4.28e-06	693	197	22	PF00096
Domain	-	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF831 ZNF479 ZNF841 ZNF577 ZNF628 ZNF473 E4F1 PRDM5 ZNF786 ZFPM2 HIVEP3 ZNF41 ZNF540 ZNF726 ZNF646	1.06e-05	679	197	21	3.30.160.60
Domain	Znf_C2H2/integrase_DNA-bd	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF831 ZNF479 ZNF841 ZNF577 ZNF628 ZNF473 E4F1 PRDM5 ZNF786 ZFPM2 HIVEP3 ZNF41 ZNF540 ZNF726 ZNF646	1.48e-05	694	197	21	IPR013087
Domain	HEAT_REPEAT	CKAP5 TEX10 PSME4 UTP20 ODAD2 INTS4	9.55e-05	70	197	6	PS50077
Domain	zf-C2H2_6	ZNF845 ZNF671 ZNF586 ZNF236 ZNF479 ZNF841 ZNF473 E4F1 PRDM5 ZNF540 ZNF726 ZNF646	1.31e-04	314	197	12	PF13912
Domain	ARM-like	CKAP5 TEX10 PSME4 UTP20 KPNA5 RANGAP1 XPO4 ODAD2 CNOT9 LTN1 INTS4	1.44e-04	270	197	11	IPR011989
Domain	MPI_Phosphatase	CDC25A CDC25B	3.30e-04	3	197	2	IPR000751
Domain	Tubulin-bd_cofactor_C_dom	TBCC TBCCD1	3.30e-04	3	197	2	IPR012945
Domain	-	RASA4B RASA4	3.30e-04	3	197	2	4.10.1130.10
Domain	M-inducer_phosp	CDC25A CDC25B	3.30e-04	3	197	2	PF06617
Domain	TBCC	TBCC TBCCD1	3.30e-04	3	197	2	PF07986
Domain	Rho_GTPase_activation_prot	STARD13 SYDE2 RASA4B ARHGAP21 PLXNA1 RASA4	3.37e-04	88	197	6	IPR008936
Domain	IPT	CAMTA2 NFKB2 PLXNA1 PKHD1L1	3.43e-04	32	197	4	IPR002909
Domain	HEAT	CKAP5 TEX10 UTP20 ODAD2 INTS4	3.61e-04	58	197	5	IPR000357
Domain	-	CKAP5 TEX10 PSME4 UTP20 KPNA5 XPO4 ODAD2 CNOT9 INTS4	5.99e-04	222	197	9	1.25.10.10
Domain	DOCK_N	DOCK4 DOCK5	1.08e-03	5	197	2	PF16172
Domain	DOCK_N	DOCK4 DOCK5	1.08e-03	5	197	2	IPR032376
Domain	CAP/MinC_C	TBCC TBCCD1	1.08e-03	5	197	2	IPR016098
Domain	CARP_motif	TBCC TBCCD1	1.08e-03	5	197	2	IPR006599
Domain	-	TBCC TBCCD1	1.08e-03	5	197	2	2.160.20.70
Domain	C-CAP_CF_C-like	TBCC TBCCD1	1.08e-03	5	197	2	IPR017901
Domain	CARP	TBCC TBCCD1	1.08e-03	5	197	2	SM00673
Domain	C_CAP_COFACTOR_C	TBCC TBCCD1	1.08e-03	5	197	2	PS51329
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 HIVEP2 MAP2 CKAP5 CDK14 PTPN3 TBC1D4 ALMS1 SYDE2 KIF14 GNAS ZNF598 DNMBP ARHGAP21 DOP1B DSC2 LIMD1 CEP162 GRB10 ZNF106 FRMD6 CDC25B	1.41e-08	861	209	22	36931259
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DOCK4 MYO1D SGO1 TTC4 CDC7 TBC1D4 ALMS1 NFKB2 KIF14 STIP1 GNAS DNMBP CASP8AP2 ELP1 BAZ1B ZDBF2 CTR9 SENP6	2.12e-08	588	209	18	38580884
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYO1D TEX10 SGO1 PTPN3 PTPN12 TBC1D4 WDR20 MKI67 KIF14 SLC39A6 STIP1 RANGAP1 AKAP5 CEP162 ELP1 XPO4 CTR9 LTN1 INTS4 CDC25A CDC25B RPA2 PHLPP2	1.04e-07	1049	209	23	27880917
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CKAP5 SLFN5 ZNF831 ERLEC1 DOCK5 TBC1D4 SYDE2 ZFR2 UTP20 STIP1 ALB BANK1 DOP1B RANGAP1 ANK1 WNT2B MROH8 ZNF592 RAI1	1.23e-07	736	209	19	29676528
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SRRM4 CDK14 PLEKHG5 PSME4 DNMBP CASP8AP2 RANGAP1 CEP162 SMCHD1 XPO4 G2E3 INO80 ZNF592 SENP6 RAI1 ZNF646	1.56e-07	529	209	16	14621295
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	EME1 ZNF845 CKAP5 SLFN5 TTF1 DOCK5 SURF6 MKI67 UTP20 TET3 CASP8AP2 RANGAP1 SMCHD1 BAZ1B PPHLN1 G2E3 E4F1 INO80 ZFC3H1 ZNF106 CTR9 INTS4 RPA2 RAI1	1.10e-06	1294	209	24	30804502
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	HOPX ZNF236 NFKB2 ZNF598 PLXNA1 DOP1B ZNF473 LIMD1 TUT7 BAZ1B PRDM5 PKHD1L1 ZNF786 HIVEP3 ZNF592 ZNF726 PHF13 ZNF646	2.19e-06	808	209	18	20412781
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MYOM1 CKAP5 SLFN5 KIF14 STIP1 CPLANE1 DSC2 SMCHD1 PPHLN1 ZFC3H1 ZNF592 CADPS2	2.20e-06	361	209	12	26167880
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	EME1 TEX10 CDC7 KPNA5 PPHLN1 ZFC3H1 ZNF106 CTR9 SENP6	8.74e-06	222	209	9	37071664
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	CKAP5 SGO1 PTPN3 MKI67 STIP1 DOP1B LIMD1 ELP1 TBCCD1 ANKRD44 INTS4 CDC25A PTGES3 PHLPP2	1.10e-05	573	209	14	28330616
Pubmed	Comparative genome mapping in the sequence-based era: early experience with human chromosome 7.	DOCK4 RASA4B RASA4	1.17e-05	8	209	3	10810084
Pubmed	Crystal structure and activity of human p23, a heat shock protein 90 co-chaperone.	HOPX STIP1 PTGES3	1.17e-05	8	209	3	10811660
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	CKAP5 TBC1D4 ALMS1 GRB10 ZMIZ1 CTR9 CADPS2	1.45e-05	130	209	7	12421765
Pubmed	Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand.	MKI67 ALB DSC2 WNT2B CADPS2	1.54e-05	52	209	5	23260145
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	MAP2 RYR3 GNAS ARHGAP21 BAZ1B ZFC3H1 LTN1 SENP6	2.20e-05	191	209	8	20195357
Pubmed	Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2.	MAP2 CHAT MKI67	2.49e-05	10	209	3	15837129
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	CKAP5 ERLEC1 PTPN3 PTPN12 STIP1 GNAS ZNF598 KPNA5 DNAJC16 SMCHD1 ELP1 XPO4 TBCCD1 CTR9 LTN1 CDC25A CDC25B PTGES3	2.73e-05	974	209	18	28675297
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DOCK4 MYO1D PLEKHG5 VPS8 LTN1 SENP6	3.46e-05	101	209	6	9872452
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIVEP2 MAP2 PLCXD1 NAIP ZNF236 CDK14 TTF1 DOCK5 TBC1D4 GNAS TET3 RECK LIMD1 GRB10 PPHLN1 G2E3 IQCN ZMIZ1 CCDC57 HIVEP3 ANKRD44 ASMTL RAI1	3.53e-05	1489	209	23	28611215
Pubmed	Butyrophilin-like 1 encodes an enterocyte protein that selectively regulates functional interactions with T lymphocytes.	BTNL8 BTNL3	3.59e-05	2	209	2	21368163
Pubmed	Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.	APOB LPA	3.59e-05	2	209	2	24859635
Pubmed	OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.	APOB LPA	3.59e-05	2	209	2	21404224
Pubmed	The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production.	DRD5 GRK4	3.59e-05	2	209	2	17259440
Pubmed	Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).	APOB LPA	3.59e-05	2	209	2	26975530
Pubmed	CDC25A phosphatase controls meiosis I progression in mouse oocytes.	CDC25A CDC25B	3.59e-05	2	209	2	18367163
Pubmed	A butyrophilin family member critically inhibits T cell activation.	BTNL8 BTNL3	3.59e-05	2	209	2	20944003
Pubmed	Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone.	CDC25A CDC25B	3.59e-05	2	209	2	17018577
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4B RASA4	3.59e-05	2	209	2	11448776
Pubmed	The ontogeny of Butyrophilin-like (Btnl) 1 and Btnl6 in murine small intestine.	BTNL8 BTNL3	3.59e-05	2	209	2	27528202
Pubmed	Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3.	HIVEP2 HIVEP3	3.59e-05	2	209	2	20404140
Pubmed	Lipoprotein (a): impact by ethnicity and environmental and medical conditions.	APOB LPA	3.59e-05	2	209	2	26637279
Pubmed	Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.	CDC25A CDC25B	3.59e-05	2	209	2	25326518
Pubmed	Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.	APOB LPA	3.59e-05	2	209	2	26515419
Pubmed	CDC25 phosphatases as potential human oncogenes.	CDC25A CDC25B	3.59e-05	2	209	2	7667636
Pubmed	Tumor-promoting action of ubiquitin protease 43 in gastric cancer progression through deubiquitination and stabilization of stress-inducible phosphoprotein 1.	USP18 STIP1	3.59e-05	2	209	2	37442266
Pubmed	DOCK4 stimulates MUC2 production through its effect on goblet cell differentiation.	DOCK4 MUC2	3.59e-05	2	209	2	33559155
Pubmed	Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells.	APOB LPA	3.59e-05	2	209	2	9548923
Pubmed	Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.	APOB LPA	3.59e-05	2	209	2	25614280
Pubmed	Sleep Duration, Lipid Profile and Insulin Resistance: Potential Role of Lipoprotein(a).	APOB LPA	3.59e-05	2	209	2	32630105
Pubmed	Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: correlation with histological subtypes and cell proliferation.	CDC25A CDC25B	3.59e-05	2	209	2	14767575
Pubmed	Overexpression of CR/periphilin downregulates Cdc7 expression and induces S-phase arrest.	CDC7 PPHLN1	3.59e-05	2	209	2	15474462
Pubmed	Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.	APOB LPA	3.59e-05	2	209	2	35045727
Pubmed	High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.	APOB LPA	3.59e-05	2	209	2	15654123
Pubmed	RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B.	CDC25A CDC25B	3.59e-05	2	209	2	23708659
Pubmed	FBXW10 promotes hepatocarcinogenesis in male patients and mice.	FBXW10B FBXW10	3.59e-05	2	209	2	31400758
Pubmed	Metrological traceability in mass spectrometry-based targeted protein quantitation: a proof-of-principle study for serum apolipoproteins A-I and B100.	APOB LPA	3.59e-05	2	209	2	24972322
Pubmed	The Suggestive Effect of Apo A, Apo B, and Apo A/Apo B on Erectile Dysfunction.	APOB LPA	3.59e-05	2	209	2	33423974
Pubmed	Chromosome mapping of human CDC25A and CDC25B phosphatases.	CDC25A CDC25B	3.59e-05	2	209	2	8276402
Pubmed	Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.	FBXW10B FBXW10	3.59e-05	2	209	2	37450367
Pubmed	Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment.	APOB LPA	3.59e-05	2	209	2	34461734
Pubmed	Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties.	HIVEP2 HIVEP3	3.59e-05	2	209	2	2247438
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4B RASA4	3.59e-05	2	209	2	16041389
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DNMBP DOP1B DNAJC16 CEP162 NLRP1 PHLPP2	3.65e-05	102	209	6	10231032
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 CKAP5 CAMTA2 ZFR2 TET3 ARHGAP21 DOP1B DNAJC16 VPS8 GRB10 ZNF365	3.97e-05	407	209	11	12693553
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP2 DGKQ EXTL3 ZNF236 PLEKHG5 PSME4 SURF6 NFKB2 DNMBP ARHGAP21 PLXNA1 ZNF628 GRB10 INO80 HIVEP3 GRAMD2A ZNF592 RAI1 KLHL17	4.31e-05	1105	209	19	35748872
Pubmed	Rna-binding protein Musashi2: developmentally regulated expression in neural precursor cells and subpopulations of neurons in mammalian CNS.	MAP2 CHAT MKI67	4.52e-05	12	209	3	11588182
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	SPAG1 CDK14 TTC4 DOCK5 PTPN3 WDR20 ARHGAP21 PLXNA1 AKAP5 DSC2 DNAJC16 GJC1 APOB	4.54e-05	569	209	13	30639242
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYO1D CKAP5 TEX10 TTF1 SURF6 MKI67 KIF14 UTP20 RANGAP1 SMCHD1 TUT7 ELP1 BAZ1B RAI1	4.60e-05	653	209	14	22586326
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MAP2 TEX10 RYR3 SURF6 ARHGAP21 ANK1 CCDC57 ZNF106 ZNF592 PDIK1L ZNF540 RAI1	5.28e-05	497	209	12	36774506
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	MAP2 NAIP ZRANB3 RAD54L SMCHD1 GRB10 CTR9 INTS4 RAI1	5.57e-05	281	209	9	24163370
Pubmed	Synteny conservation of the Huntington's disease gene and surrounding loci on mouse Chromosome 5.	ALB DRD5 GRK4	7.42e-05	14	209	3	7919654
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	DOCK5 PTPN3 SYDE2 SURF6 WDR20 MKI67 ALB ARHGAP21 DSC2 DNAJC16 CEP162 APOB PKHD1L1 FRMD6 PTGES3	8.01e-05	777	209	15	35844135
Pubmed	The familial dysautonomia disease gene IKBKAP is required in the developing and adult mouse central nervous system.	CHAT MKI67 ELP1	9.23e-05	15	209	3	28167615
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HIVEP2 CKAP5 EXTL3 RYR3 SURF6 ZNF841 PIP4P2 ARHGAP21 RECK DOP1B ZNF473 ZFC3H1 ZNF365 RNF220 RPRD1A ZNF592 CTR9 SENP6 CADPS2 PTGES3	1.06e-04	1285	209	20	35914814
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	HOPX CAMTA2 ZRANB3 PSME4 CPLANE1 ARHGAP21 ZNF473 CEP162 TUT7 BAZ1B G2E3 APOB INO80 TBCCD1 GRAMD2A CTR9 LTN1 ZNF726	1.07e-04	1084	209	18	11544199
Pubmed	Genome-wide DNA methylation analysis implicates enrichment of interferon pathway in African American patients with Systemic Lupus Erythematosus and European Americans with lupus nephritis.	USP18 MX1	1.07e-04	3	209	2	37506491
Pubmed	Cdc25A Is a Critical Mediator of Ischemic Neuronal Death In Vitro and In Vivo.	CDC25A CDC25B	1.07e-04	3	209	2	28607169
Pubmed	CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.	RASA4B RASA4	1.07e-04	3	209	2	25637021
Pubmed	Oocytes progress beyond prophase in the presence of DNA damage.	CDC25A CDC25B	1.07e-04	3	209	2	22578416
Pubmed	Cell cycle regulation by the Cdc25 phosphatase family.	CDC25A CDC25B	1.07e-04	3	209	2	10740819
Pubmed	Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants.	VEGFD APOB	1.07e-04	3	209	2	30354205
Pubmed	Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins Gs and Gz.	GNAS DRD5	1.07e-04	3	209	2	9603210
Pubmed	Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression.	CDC25A CDC25B	1.07e-04	3	209	2	30718768
Pubmed	Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.	APOB LPA	1.07e-04	3	209	2	23701995
Pubmed	Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).	APOB LPA	1.07e-04	3	209	2	23973688
Pubmed	CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.	MKI67 CDC25B	1.07e-04	3	209	2	24344030
Pubmed	Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.	CDC25A CDC25B	1.07e-04	3	209	2	26474275
Pubmed	The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes.	APOB LPA	1.07e-04	3	209	2	22407494
Pubmed	The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks.	EME1 RAD54L	1.07e-04	3	209	2	17036055
Pubmed	Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.	LIMD1 CDC25A	1.07e-04	3	209	2	29672635
Pubmed	Dampening of death pathways by schnurri-2 is essential for T-cell development.	HIVEP2 HIVEP3	1.07e-04	3	209	2	21475200
Pubmed	Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer.	BTNL8 BTNL3	1.07e-04	3	209	2	32375678
Pubmed	Role of DNA methylation and histone H3 lysine 27 methylation in tissue-specific imprinting of mouse Grb10.	MAP2 GRB10	1.07e-04	3	209	2	17101788
Pubmed	Two CDC25 homologues are differentially expressed during mouse development.	CDC25A CDC25B	1.07e-04	3	209	2	7635051
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CKAP5 TEX10 TTF1 LENG8 SURF6 WDR20 KIF14 UTP20 STIP1 ZNF598 DNMBP DNAJC16 BAZ1B PPHLN1 E4F1 INO80 ZFC3H1 GTPBP10 CNOT9 ZNF592 CTR9 LTN1	1.08e-04	1497	209	22	31527615
Pubmed	IRF6 and AP2A Interaction Regulates Epidermal Development.	MKI67 DSC2 GRHL3	1.13e-04	16	209	3	29913133
Pubmed	Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons.	MAP2 HOPX MKI67	1.13e-04	16	209	3	16410412
Pubmed	Postnatal liver functional maturation requires Cnot complex-mediated decay of mRNAs encoding cell cycle and immature liver genes.	MKI67 ALB CDC25A CDC25B	1.30e-04	43	209	4	30733279
Pubmed	Prickle1 is expressed in distinct cell populations of the central nervous system and contributes to neuronal morphogenesis.	MAP2 CHAT MKI67	1.37e-04	17	209	3	23420014
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STARD13 EME1 SPAG1 MYO1D TEX10 SGO1 ERLEC1 C4orf17 ARHGAP21 CACNA1E RANGAP1 AKAP5 DRD5 SMCHD1 APOB ZFC3H1 CCDC57 CTR9 CFAP74 CADPS2 RAI1	1.77e-04	1442	209	21	35575683
Pubmed	Molecular characterization of mutant mouse strains generated from the EUCOMM/KOMP-CSD ES cell resource.	MAP2 SRRM4 ZNF106	1.93e-04	19	209	3	23912999
Pubmed	Response of small intestinal epithelial cells to acute disruption of cell division through CDC25 deletion.	CDC25A CDC25B	2.14e-04	4	209	2	19273838
Pubmed	Survey on amacrine cells coupling to retrograde-identified ganglion cells in the mouse retina.	CHAT GJC1	2.14e-04	4	209	2	23821205
Pubmed	Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.	CDC25A CDC25B	2.14e-04	4	209	2	22899714
Pubmed	RFWD3 promotes ZRANB3 recruitment to regulate the remodeling of stalled replication forks.	ZRANB3 RPA2	2.14e-04	4	209	2	37036693
Pubmed	Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments.	BTNL8 BTNL3	2.14e-04	4	209	2	27641500
Pubmed	Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations.	CHAT GNAS	2.14e-04	4	209	2	27991864
Pubmed	Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding.	RASA4B RASA4	2.14e-04	4	209	2	16234249
Pubmed	Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3.	CCL7 CCR10	2.14e-04	4	209	2	9364936
Pubmed	Ankyrin-R regulates fast-spiking interneuron excitability through perineuronal nets and Kv3.1b K+ channels.	CHAT ANK1	2.14e-04	4	209	2	34180393
Interaction	DHX40 interactions	TEX10 LENG8 SURF6 KIF14 UTP20 PPHLN1 ZDBF2 ZFC3H1 GTPBP10 ZNF106 CTR9 RPA2 PTGES3 RAI1	2.63e-07	249	204	14	int:DHX40
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF132 ZNF845 ZNF671 ZNF586 HIVEP2 ZNF236 ZNF479 ZNF841 ZNF598 ZNF577 ZNF628 ZNF473 E4F1 PRDM5 ZNF365 ZNF786 ZFPM2 HIVEP3 ZNF106 ZNF592 ZNF41 ZNF540 ZNF726 ZNF646	3.20e-09	718	146	24	28
GeneFamily	Class III Cys-based CDC25 phosphatases	CDC25A CDC25B	1.93e-04	3	146	2	713
Coexpression	FISCHER_DREAM_TARGETS	EME1 CKAP5 SGO1 TTF1 ZRANB3 CDC7 ALMS1 MKI67 KIF14 STIP1 RAD54L CASP8AP2 RANGAP1 ZNF473 SMCHD1 BAZ1B G2E3 CNOT9 FKBP7 CDC25A CDC25B RPA2 PTGES3	2.81e-06	969	207	23	M149
Coexpression	SENESE_HDAC3_TARGETS_UP	DOCK4 HIVEP2 MAP2 PLCXD1 SLFN5 EXTL3 PTPN12 TBC1D4 PSME4 NFKB2 SLC39A6 STIP1 TSGA10 GRB10 ZNF41	1.02e-05	495	207	15	M8451
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	EME1 ZNF845 CKAP5 TEX10 SGO1 TTF1 ZRANB3 PTPN12 PSME4 ALMS1 KCNJ15 MKI67 UTP20 STIP1 CPLANE1 PIP4P2 ARHGAP21 RAD54L CASP8AP2 SMCHD1 GRK4 TSGA10 BAZ1B NLRP1 PPHLN1 G2E3 ZDBF2 CNOT9 CFAP74	5.88e-06	1257	198	29	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	EME1 ZNF845 MAP2 CKAP5 TEX10 SGO1 TTF1 ZRANB3 PTPN12 PSME4 ALMS1 KCNJ15 MKI67 UTP20 STIP1 CPLANE1 PIP4P2 ARHGAP21 RAD54L CASP8AP2 SMCHD1 GRK4 TSGA10 BAZ1B NLRP1 PPHLN1 G2E3 ZDBF2 CNOT9 CFAP74	3.64e-05	1459	198	30	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	EME1 ZNF845 MAP2 CKAP5 TEX10 SGO1 CDK14 RAB38 PTPN12 PSME4 ALMS1 GVINP1 KCNJ15 MKI67 STIP1 CPLANE1 CASP8AP2 GRK4 TSGA10 PPHLN1 G2E3 PRDM5 GTPBP10 ZNF41 CTR9 GAB3 FKBP7	4.16e-05	1252	198	27	facebase_RNAseq_e10.5_MaxArch_2500_K3
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	USP18 ZNF132 HIVEP2 SAMD9 MAP2 ALDH8A1 SLFN5 PLEKHG5 SMCHD1 MX1	3.42e-08	198	208	10	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTPN12 MKI67 KIF14 MSS51 ZNF598 ZNF786 TBCCD1 CDC25B RPA2	1.92e-07	181	208	9	c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EME1 SGO1 ALMS1 MKI67 RAD54L AKAP5 MROH8 INTS4 CDC25A	1.92e-07	181	208	9	e4dbc09f0210de465d8347969b301c22463a2b7d
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	B4GALNT1 SGO1 RYR3 MKI67 KIF14 TSSK3 RAD54L GJC1	2.06e-07	132	208	8	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	Control-Control-Myeloid-Neutrophil\|Control / Disease, condition lineage and cell class	BTNL8 ACSM1 EXTL3 DOCK5 PTPN12 KCNJ15 SMCHD1 NLRP1 PRDM5	4.45e-07	200	208	9	95c41f147a1594d49e73cb56d86d301c3115ce20
ToppCell	(01)_Cycling_Basal_(homeostasis)\|World / shred by cell type and Timepoint	EME1 CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	1.90e-06	177	208	8	05c57578142a6662f18b294d5cc11e6efd6b0f8e
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EME1 CKAP5 SGO1 CDC7 MKI67 KIF14 RANGAP1 G2E3	2.16e-06	180	208	8	5e1680088065be14447d5d5465f91f7edd071a1e
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGO1 DOCK5 MKI67 PLXNA1 PPHLN1 RPRD1A PDIK1L CDC25B	2.25e-06	181	208	8	3fe648db1cb8326066d8bde3ca1287c5c9af19bd
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CKAP5 SGO1 MKI67 KIF14 GNAS RANGAP1 G2E3 CDC25B	3.90e-06	195	208	8	742c82c86487314cdb3178012004adb1164bcbdb
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T\|COVID-19_Mild / Disease, condition lineage and cell class	HIVEP2 SAMD9 SLFN5 ZNF831 TBC1D4 MKI67 AKAP5 CDC25B	4.53e-06	199	208	8	f307d4887b28cf60a591439e278fd668409cb104
ToppCell	Control-Control-Lymphocyte-T/NK-dn_T\|Control / Disease, condition lineage and cell class	HIVEP2 ACSM1 SLFN5 TBC1D4 MKI67 TSSK3 TRBV20-1 CDC25B	4.70e-06	200	208	8	10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-Treg\|Int-URO / Disease, condition lineage and cell class	SLFN5 TBC1D4 GALNT8 CCR10 ZDBF2 ZNF365 TRBV20-1 CDC25B	4.70e-06	200	208	8	47f265336bc3b8052c0cac730ac9afd41cd8fc43
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGO1 CDC7 PTPN3 ALMS1 KIF14 RAD54L WDR5B	9.64e-06	158	208	7	ee8ce3cd202807df692b28bb1a81827d49d73862
ToppCell	Int-URO-Lymphocyte-T_NK-Treg\|Int-URO / Disease, Lineage and Cell Type	SLFN5 TBC1D4 GALNT8 CCR10 ZDBF2 ZNF365 CDC25B	9.64e-06	158	208	7	457d64dceedb67bfff1303334cda1253a839b3d6
ToppCell	FLU-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	USP18 PLXNA1 AKAP5 IQCN ZNF365 GAB3 MX1	1.00e-05	159	208	7	97c8e16a7ac10ebba96daee97f9fb1d4a404f23b
ToppCell	FLU-Healthy-1\|FLU / Virus stimulation, Condition and Cluster	USP18 PLXNA1 AKAP5 IQCN ZNF365 GAB3 MX1	1.00e-05	159	208	7	fe2a9f79b058e89214256e736f6e266830cdfa28
ToppCell	facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERLEC1 PTPN12 TBC1D4 DNMBP CCR10 SMCHD1 ZFPM2	1.38e-05	167	208	7	961e722442d786ab15d1e490941d2be265a9057a
ToppCell	facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERLEC1 PTPN12 TBC1D4 DNMBP CCR10 SMCHD1 ZFPM2	1.38e-05	167	208	7	3760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 NDST4 CHAT ZNF831 PIK3CG ITPRID1 TTLL2	1.55e-05	170	208	7	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 SGO1 CDC7 MKI67 RAD54L GJC1 ZFPM2	1.61e-05	171	208	7	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP2 SGO1 CDC7 MKI67 RAD54L GJC1 ZFPM2	1.61e-05	171	208	7	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	droplet-Fat-Mat-18m-Lymphocytic-lymphocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 ALDH8A1 GVINP1 BANK1 SMCHD1 ANKRD44 KLK8	1.67e-05	172	208	7	226de1a5d4a360d3ae01b0235fea19521ec623a0
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 ZRANB3 C4orf17 SYDE2 MKI67 RGS5 CFAP74	1.87e-05	175	208	7	d8e385320f554d974538b7cdc4f8e4767f1455f2
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP2 HOPX PTPN3 AKAP5 XPO4 ZNF365 GRAMD2A	1.87e-05	175	208	7	442f261a3b2c4d2523f7d4089178f8c79cac2f0f
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP2 HOPX PTPN3 AKAP5 XPO4 ZNF365 GRAMD2A	1.87e-05	175	208	7	35fb7735dd3355476fe60404833cb60bd066bcf1
ToppCell	facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 ZRANB3 C4orf17 SYDE2 MKI67 RGS5 CFAP74	1.87e-05	175	208	7	cf15465855602ba135752c18755e3e058dbd42ec
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	EME1 SGO1 TTC4 MKI67 KIF14 RNF212 CDC25A	2.16e-05	179	208	7	ec69e1dd897414033ba5b007aa82655a79adca6c
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLCXD1 CKAP5 SGO1 MKI67 KIF14 RAD54L ZNF473	2.24e-05	180	208	7	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	IIH-cycling-\|IIH / Condition, Cell_class and T cell subcluster	EME1 SPAG1 SGO1 MKI67 KIF14 RAD54L CDC25A	2.32e-05	181	208	7	7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078
ToppCell	IIH-cycling\|IIH / Condition, Cell_class and T cell subcluster	EME1 SPAG1 SGO1 MKI67 KIF14 RAD54L CDC25A	2.32e-05	181	208	7	ec3e782ce93dcfe1a54fb7284e4e39063614b0e2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EME1 CKAP5 SGO1 MKI67 KIF14 G2E3 ZNF726	2.41e-05	182	208	7	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYO1D HOPX PIK3CG CACNA1E FRMD6 ZNF804B CADPS2	2.41e-05	182	208	7	35b2a5625323bf0917214d3b82fafc4a8f5e75ff
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HOPX PP2D1 KIF9 FBXW10 WDR5B ZNF473 TBCCD1	2.49e-05	183	208	7	dc9602bed3136db91faeffef177006246dc92743
ToppCell	severe-multiplets\|severe / disease stage, cell group and cell class	SGO1 ZNF831 KIF14 RAD54L RANGAP1 LIMD1 RNF212	2.49e-05	183	208	7	78af8df48f0fe49ac37ccec0ad7b2993883b1148
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	PLCXD1 WSB2 SGO1 MKI67 KIF14 CDC25A CDC25B	2.49e-05	183	208	7	a716b446c2bf5aa294b8f580aa845098fae76354
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SGO1 TSSK3 DSC2 ZNF804B GRHL3	2.50e-05	74	208	5	c68b00cf7d2cec7951b78e2c6710d7770b02566a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SGO1 TSSK3 DSC2 ZNF804B GRHL3	2.50e-05	74	208	5	bad24c9251ef44c05f3390073732a467aaeefe1e
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	SGO1 TSSK3 DSC2 ZNF804B GRHL3	2.50e-05	74	208	5	195fd37345a394c0b60f713bedadf6fd08dc050c
ToppCell	Control-CD8+_T_activated\|Control / Disease group and Cell class	USP18 PIK3CG KPNA5 DNAI3 ASMTL RAI1 MX1	2.58e-05	184	208	7	b86cc48b744b3206880ec1373fe6068e14bf9680
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EME1 SGO1 MKI67 KIF14 RAD54L ZCCHC4 CDC25A	2.67e-05	185	208	7	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EME1 CKAP5 SGO1 MKI67 KIF14 RAD54L RANGAP1	2.67e-05	185	208	7	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	EME1 SGO1 TTC4 MKI67 KIF14 RNF212 CDC25A	2.77e-05	186	208	7	799903b68bc6f6205d004b44c603424b0d5f7c32
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYO1D ERLEC1 MKI67 KIF14 CCR10 PKHD1L1 CADPS2	2.86e-05	187	208	7	88d20f150df61ef0e3ee0c3e9895b094920c4b09
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYO1D ERLEC1 MKI67 KIF14 CCR10 PKHD1L1 CADPS2	2.86e-05	187	208	7	158c2c003fd225ba61793fb06eece232fb063d05
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	EME1 B4GALNT1 SGO1 MKI67 KIF14 RAD54L CDC25A	2.96e-05	188	208	7	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTPN12 MKI67 KIF14 ZNF598 TBCCD1 CDC25B RPA2	2.96e-05	188	208	7	34873972dff9284dfcd26bb698c9d1df007f1cbb
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	HOPX SLFN5 LENG8 RASA4B GNAS ANKRD44 GAB3	3.06e-05	189	208	7	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKAP5 SGO1 MKI67 KIF14 CCL7 RAD54L PRDM5	3.17e-05	190	208	7	b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	3.17e-05	190	208	7	cd37ccd30c27cf65eda0a9165f35b7672f5acaf6
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EME1 SGO1 CDC7 MKI67 RAD54L CDC25B RPA2	3.28e-05	191	208	7	239300ff76f2c855b2b04d3002461158be90a01b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	3.28e-05	191	208	7	0ba5b112a82e489f5a21966f78a403a7436ce73b
ToppCell	droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EME1 CKAP5 SGO1 MKI67 KIF14 G2E3 CDC25B	3.39e-05	192	208	7	96f23d6e8604d1cb24910d3118d8171b57c93e14
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	3.39e-05	192	208	7	026f3e38970bea1e6e8d76a4e2becdfb8484b2ff
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GTSF1 ZNF845 SAMD9 SLFN5 AKAP5 ZNF786 SPATA9	3.62e-05	194	208	7	6be74e4ba631b0c46cef2c580553f4c1ed29579e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EME1 SGO1 CDC7 MKI67 KIF14 RAD54L CDC25A	3.62e-05	194	208	7	4c1d13d8cb6fb424655c67755ee6dbaf59d6b418
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CKAP5 SGO1 CDC7 MKI67 KIF14 RANGAP1 G2E3	3.86e-05	196	208	7	0644bd14a944b9c9759a295dfdd5e67a4775f20a
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FBXW10B EME1 KIF14 WDR49 FBXW10 ODAD2 DNAI3	3.99e-05	197	208	7	861e8df9bd74dc5e17bafdc1fb3fef546753c73a
ToppCell	T_cells-Treg_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	HIVEP2 BTNL8 CDK14 TBC1D4 ANK1 ZDBF2 MX1	3.99e-05	197	208	7	ec9398ae3577f61d6b1e6aba50ef4261aaaa7610
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGO1 MKI67 KIF14 RAD54L RGS5 PKHD1L1 CDC25B	3.99e-05	197	208	7	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	mild-Treg\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 SLFN5 ZNF831 TBC1D4 CCR10 SMCHD1 MX1	3.99e-05	197	208	7	39800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / Treatment groups by lineage, cell group, cell type	SGO1 MKI67 KIF14 KPNA5 RANGAP1 FICD RPA2	3.99e-05	197	208	7	038fd92750257d43d5e980fd06d77742b543f11a
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	STARD13 MYO1D KCNJ15 RASA4B CCL7 CPLANE1	3.99e-05	134	208	6	9e12aac8f42790c2f104dfd61c87aa99fc7925f1
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SRRM4 FBXW10 WDR5B ANK1 GTPBP10 SPATA9	3.99e-05	134	208	6	a4b9163af68e92d047b0005fd2f98aa63846b65b
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EME1 KIF14 WDR49 ZNF473 ODAD2 DNAI3 CFAP74	4.12e-05	198	208	7	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	4.12e-05	198	208	7	5f0964c3aa7e1dc52cbb46e754078920b65bcb88
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma\|TCGA-Breast / Sample_Type by Project: Shred V9	CKAP5 SGO1 MKI67 KIF14 STIP1 RAD54L CDC25A	4.12e-05	198	208	7	880f9817f5145f10f29fc05c5866090433532fe2
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	4.12e-05	198	208	7	629d674a9c9108c1acb3f7af57bbdbf34bb0528e
ToppCell	MS-cycling-\|MS / Condition, Cell_class and T cell subcluster	EME1 SGO1 MKI67 KIF14 RAD54L CCR10 PKHD1L1	4.12e-05	198	208	7	19c5d6b65de490118574b1f86b45c58b3a51df7f
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	4.12e-05	198	208	7	c3dd887c95587f930b7afd32385627a9fa029ca4
ToppCell	MS-cycling\|MS / Condition, Cell_class and T cell subcluster	EME1 SGO1 MKI67 KIF14 RAD54L CCR10 PKHD1L1	4.12e-05	198	208	7	0c22f2cc0e5ca91cabcd4aac2b9ef05af47e967f
ToppCell	severe-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYO1D CDK14 ERLEC1 CCR10 PKHD1L1 CDC25A CADPS2	4.25e-05	199	208	7	6ee4c2e6049860071169366b7e662d5c1a3cc54b
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SPAG1 SAMD9 SLFN5 ERLEC1 GNAS CEP162 MAP4K5	4.25e-05	199	208	7	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	CKAP5 SGO1 MKI67 KIF14 RANGAP1 G2E3 CDC25B	4.25e-05	199	208	7	ca17e8c0f5bc2c41ce28351a7418d934404e563b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HOPX SGO1 CDC7 MKI67 KIF14 RAD54L CDC25A	4.25e-05	199	208	7	101f78fe6dd1bf9e2e4dd5ad8a970312b3540927
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HOPX SGO1 CDC7 MKI67 KIF14 RAD54L CDC25A	4.25e-05	199	208	7	e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell	Healthy_donor-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	EME1 SGO1 PTPN3 MKI67 KIF14 RAD54L CDC25A	4.25e-05	199	208	7	1311dfd74b991f48b047a439f04f9bf7dfaa0e7a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EME1 CDC7 MKI67 KIF14 RAD54L CDC25A ZNF726	4.25e-05	199	208	7	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CKAP5 SGO1 MKI67 KIF14 RAD54L RANGAP1 CDC25A	4.25e-05	199	208	7	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EME1 CKAP5 SGO1 MKI67 KIF14 RAD54L G2E3	4.25e-05	199	208	7	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	medial-Hematologic-Proliferating_NK/T-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EME1 SGO1 CDC7 MKI67 KIF14 RAD54L CDC25A	4.39e-05	200	208	7	ab1f9f99cb4a381a642a2cfb32e7f8d276c2dda4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP18 SAMD9 SLFN5 SMCHD1 ZFC3H1 ANKRD44 MX1	4.39e-05	200	208	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	3'_v3-Lung-Lymphocytic_NK-Cycling_NK\|Lung / Manually curated celltypes from each tissue	EME1 SGO1 MKI67 KIF14 RAD54L CDC25A CDC25B	4.39e-05	200	208	7	381bafdde6492f020ae93ab8fffa6215c631c570
ToppCell	medial-Hematologic-Proliferating_NK/T\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EME1 SGO1 CDC7 MKI67 KIF14 RAD54L CDC25A	4.39e-05	200	208	7	bfde42e00a9a6b858937de87cd19c9ed3677d954
ToppCell	medial-2-Hematologic-Proliferating_NK/T\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EME1 SGO1 CDC7 MKI67 KIF14 RAD54L CDC25A	4.39e-05	200	208	7	3d1895490dd262e9246eb280938239a7253451dd
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Mesoderm\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	ZNF845 SLC22A15 PLEKHG5 KPNA5 ANK1 WNT2B	4.89e-05	139	208	6	d441c29852c28928ecb696b4b95e31b30c17116b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RGS5 XPO4 APOB ZDBF2 GAB3 INTS4	6.19e-05	145	208	6	42dd36c1bc2c43cfea7196e89f901e4ea2a403c7
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8\|TCGA-Bladder / Sample_Type by Project: Shred V9	BHMT DNAJC16 ZNF786 PDIK1L GRHL3 ZNF726	7.47e-05	150	208	6	1aa9320d97ff10994ea024751790524fe133aba9
ToppCell	IIH-CD8-exh_CD4\|IIH / Condition, Cell_class and T cell subcluster	ZNF132 ZNF831 PTPN3 RPRD1A SPATA9 PHF13	8.64e-05	154	208	6	a2f51a3c5455fe2483e438375ea856afce8262fe
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|Liver / Manually curated celltypes from each tissue	ZNF586 SYDE2 GRK4 ZNF365 ZNF726 RAI1	8.64e-05	154	208	6	c6308074468235c88ef4ea43ab155d9f86cbf261
ToppCell	facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 MAP2 DGKQ CCR10 ANK1 CDC25B	9.28e-05	156	208	6	5caefdc6cc86f2ac52abe8c8da821db14f476915
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	B4GALNT1 CHAT PIK3CG TSSK3 LIMD1 ITPRID1	9.28e-05	156	208	6	58b9520fce6e259b36c3d59e82b712f5e7729e3e
ToppCell	facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRINP3 MAP2 DGKQ CCR10 ANK1 CDC25B	9.28e-05	156	208	6	758f57dc10fc5cad200bf5b310c10ec9b1405f23
ToppCell	facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF14 BANK1 WDR5B CEP162 ODAD2 ANKRD44	9.61e-05	157	208	6	0fecc14959c4c9efc19d5c06475a890e0a30f148
ToppCell	10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)\|bone_marrow / Manually curated celltypes from each tissue	CCDC168 MKI67 RAD54L RGS5 GJC1 CDC25A	9.61e-05	157	208	6	d4da4057917dda066da0f2aac2621fdaf1fb943b
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLFN5 TBC1D4 MKI67 CCR10 TRBV20-1 CDC25B	1.10e-04	161	208	6	b24293fdae9637983fcf4f2d4659a3554e00a53f
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SLFN5 TBC1D4 MKI67 CCR10 TRBV20-1 CDC25B	1.10e-04	161	208	6	eddcbe266d4a84a340fa8f2128d2b7e293968dca
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CDC7 KIF9 MSS51 RAD54L XPO4 INO80	1.18e-04	163	208	6	ce07bc424ef99c547588b07f5c8b39ff0773ca9b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FBXW10B SRRM4 ACSM1 WDR5B ZCCHC4 PDIK1L	1.26e-04	165	208	6	50f1fa7434ebb777e15d5273d1ff41070cff6db3
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 SLFN5 TBC1D4 CCR10 SMCHD1 MX1	1.26e-04	165	208	6	dbe231d00843cae917efd1abea6079ace3b45cdf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SAMD9 SLFN5 TBC1D4 CCR10 SMCHD1 MX1	1.26e-04	165	208	6	9ccce713d4122054bf4bef4a7126d90cf9141b84
Disease	cardiovascular disease	HIVEP2 ZNF831 BANK1 WNT2B APOB ODAD2 ZFPM2 C3P1 MAP4K5 LPA CDC25A CADPS2 PHF13	1.60e-05	457	200	13	EFO_0000319
Disease	cholesteryl esters to total lipids in large LDL percentage	APOB APOC4 MAP4K5 LPA	5.58e-05	31	200	4	EFO_0022249
Disease	phospholipids in very large HDL measurement	BANK1 APOB APOC4 MAP4K5 LPA	8.69e-05	66	200	5	EFO_0022298
Disease	level of spermatogenesis-associated protein 46 in blood serum	APOB APOC4	1.37e-04	3	200	2	OBA_2044829
Disease	vulva squamous cell carcinoma (is_marker_for)	CDC25A CDC25B	1.37e-04	3	200	2	DOID:2101 (is_marker_for)
Disease	Growth abnormality	TET3 ZMIZ1	1.37e-04	3	200	2	C0262361
Disease	high density lipoprotein particle size measurement	DGKQ BANK1 APOB APOC4 MAP4K5 LPA RAI1	1.68e-04	170	200	7	EFO_0008592
Disease	protein C measurement	BAZ1B FRMD6 MAP4K5	1.94e-04	17	200	3	EFO_0004633
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB APOC4 MAP4K5 LPA	2.06e-04	43	200	4	EFO_0022290
Disease	cholesterol in large HDL measurement	BANK1 APOB APOC4 MAP4K5 LPA	2.17e-04	80	200	5	EFO_0021900
Disease	cholesterol to total lipids in large VLDL percentage	APOB APOC4 MAP4K5 LPA	2.46e-04	45	200	4	EFO_0022236
Disease	cerebral infarction (is_marker_for)	BRINP3 APOB LPA	2.74e-04	19	200	3	DOID:3526 (is_marker_for)
Disease	total lipids in lipoprotein particles measurement	APOB APOC4 MAP4K5 LPA	3.16e-04	48	200	4	EFO_0022309
Disease	cholesteryl esters to total lipids in small VLDL percentage	APOB APOC4 MAP4K5 LPA	3.42e-04	49	200	4	EFO_0022256
Disease	cholesteryl esters to total lipids in IDL percentage	BANK1 APOB MAP4K5 LPA	3.70e-04	50	200	4	EFO_0022247
Disease	mucositis (biomarker_via_orthology)	MKI67 MUC2	4.51e-04	5	200	2	DOID:0080178 (biomarker_via_orthology)
Disease	total phospholipids in lipoprotein particles measurement	APOB APOC4 MAP4K5 LPA	4.63e-04	53	200	4	EFO_0022315
Disease	total lipids in medium VLDL	APOB APOC4 MAP4K5 LPA	4.97e-04	54	200	4	EFO_0022153
Disease	triglycerides in medium HDL measurement	APOB APOC4 MAP4K5 LPA	4.97e-04	54	200	4	EFO_0022321
Disease	DnaJ homolog subfamily B member 11 measurement	ZFPM2 TBCCD1	6.74e-04	6	200	2	EFO_0801537
Disease	galectin-7 measurement	APOB ZFPM2	6.74e-04	6	200	2	EFO_0022034
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	BANK1 APOB ZNF106 MAP4K5 LPA	6.96e-04	103	200	5	EFO_0008595, EFO_0020944
Disease	cholesterol to total lipids in IDL percentage	BANK1 APOB MAP4K5 LPA	7.42e-04	60	200	4	EFO_0022233
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	APOB ZNF106 MAP4K5 LPA	7.90e-04	61	200	4	EFO_0008317, EFO_0008596, EFO_0020946
Disease	triglycerides to total lipids in IDL percentage	BANK1 APOB MAP4K5 LPA	8.93e-04	63	200	4	EFO_0022329
Disease	Cholestasis	ALDH8A1 ERLEC1 CCL7 GNAS CADPS2	9.36e-04	110	200	5	C0008370
Disease	mammographic density percentage	GVINP1 TET3 ZNF365	9.84e-04	29	200	3	EFO_0006502
Disease	total lipids in very large HDL measurement	BANK1 APOB MAP4K5 LPA	1.06e-03	66	200	4	EFO_0022312
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	BANK1 APOB APOC4 ZNF106	1.12e-03	67	200	4	EFO_0008595, EFO_0020946
Disease	triglycerides to phosphoglycerides ratio	BANK1 APOB MAP4K5 LPA	1.19e-03	68	200	4	EFO_0022327
Disease	creatinine measurement, glomerular filtration rate	PTPN12 ALMS1 DNAJC16 INO80 MAP4K5	1.23e-03	117	200	5	EFO_0004518, EFO_0005208
Disease	insulin sensitivity measurement, insulin response measurement	ANK1 GRB10	1.25e-03	8	200	2	EFO_0004471, EFO_0008473
Disease	mammographic density percentage, mammographic density measurement	TMEM184B ZNF365	1.25e-03	8	200	2	EFO_0005941, EFO_0006502
Disease	Intestinal Diseases	SAMD9 SGO1	1.25e-03	8	200	2	C0021831
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	BAZ1B APOB MAP4K5 MX1	1.26e-03	69	200	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	triglycerides to total lipids in very small VLDL percentage	STIP1 APOB MAP4K5 LPA	1.26e-03	69	200	4	EFO_0022341
Disease	cholesterol in very large HDL measurement	BANK1 APOB MAP4K5 LPA	1.26e-03	69	200	4	EFO_0022229
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	DGKQ APOB ZMIZ1 APOC4 ZFPM2 MAP4K5 LPA RAI1	1.37e-03	312	200	8	EFO_0004612, EFO_0010351
Disease	cholesteryl esters to total lipids in very small VLDL percentage	BANK1 APOB MAP4K5 LPA	1.40e-03	71	200	4	EFO_0022259
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	BANK1 APOB ZNF106 MAP4K5 LPA	1.43e-03	121	200	5	EFO_0008595, EFO_0020943
Disease	triglycerides to total lipids in small HDL percentage	BANK1 APOB MAP4K5 LPA	1.47e-03	72	200	4	EFO_0022336
Disease	phospholipids in large HDL measurement	BANK1 APOB APOC4 LPA	1.55e-03	73	200	4	EFO_0022190
Disease	DCN1-like protein 5 measurement	APOC4 MAP4K5	1.59e-03	9	200	2	EFO_0801520
Disease	insulin response measurement	ANK1 GRB10	1.59e-03	9	200	2	EFO_0008473
Disease	total lipids in large HDL	BANK1 APOB APOC4 LPA	1.63e-03	74	200	4	EFO_0022189
Disease	free cholesterol to total lipids in large LDL percentage	BANK1 APOB MAP4K5 LPA	1.63e-03	74	200	4	EFO_0022280
Disease	Cardiovascular Diseases	ALB APOB LPA	1.86e-03	36	200	3	C0007222
Disease	triacylglycerol 52:4 measurement	KCNJ15 APOB MAP4K5	1.86e-03	36	200	3	EFO_0010416
Disease	choline measurement	APOB APOC4 ZFPM2 MAP4K5 LPA	1.96e-03	130	200	5	EFO_0010116
Disease	level of Triacylglycerol (51:3) in blood serum	APOB MAP4K5	1.98e-03	10	200	2	OBA_2045163
Disease	quinone oxidoreductase-like protein 1 measurement	APOC4 MAP4K5	1.98e-03	10	200	2	EFO_0021880
Disease	allergic conjunctivitis (is_marker_for)	CCL7 MUC2	1.98e-03	10	200	2	DOID:11204 (is_marker_for)
Disease	free cholesterol to total lipids in large VLDL percentage	APOB APOC4 LPA	2.01e-03	37	200	3	EFO_0022281
Disease	cholesteryl esters to total lipids in medium LDL percentage	APOB MAP4K5 LPA	2.01e-03	37	200	3	EFO_0022252
Disease	free cholesterol in large HDL measurement	BANK1 APOB MAP4K5 LPA	2.07e-03	79	200	4	EFO_0022157
Disease	phosphatidylcholine 32:1 measurement	GVINP1 CEP162 MAP4K5	2.17e-03	38	200	3	EFO_0010373
Disease	Antihypertensive use measurement	HIVEP2 ZNF831 WNT2B INO80 ZFPM2 CDC25A PTGES3	2.29e-03	265	200	7	EFO_0009927
Disease	triglycerides to total lipids in large VLDL percentage	APOB APOC4 LPA	2.34e-03	39	200	3	EFO_0022332
Disease	degree of unsaturation measurement	APOB MAP4K5 LPA	2.34e-03	39	200	3	EFO_0022261
Disease	Macrocephaly	TET3 CACNA1E	2.42e-03	11	200	2	C0221355
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	APOB MAP4K5	2.42e-03	11	200	2	OBA_2045170
Disease	Barrett's esophagus (is_marker_for)	MKI67 MUC2	2.42e-03	11	200	2	DOID:9206 (is_marker_for)
Disease	lipoprotein-associated phospholipase A(2) measurement	APOB MAP4K5 LPA	2.52e-03	40	200	3	EFO_0004746
Disease	lysophosphatidylethanolamine measurement	SLC22A15 MAP4K5 KLHL17	2.71e-03	41	200	3	EFO_0010225
Disease	testosterone measurement	STARD13 DOCK4 SPEM3 DOCK5 DNMBP BANK1 ARHGAP21 RGS5 TUT7 WNT2B BAZ1B IQCN ZMIZ1 ZFPM2 C3P1 MAP4K5 C18orf63 RAI1	2.74e-03	1275	200	18	EFO_0004908
Disease	tumor protein p53-inducible protein 11 measurement	APOC4 MAP4K5	2.89e-03	12	200	2	EFO_0802169
Disease	inactive gamma-glutamyltranspeptidase 2 measurement	APOC4 MAP4K5	2.89e-03	12	200	2	EFO_0801692
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	DGKQ BANK1 APOB MAP4K5 LPA RAI1	2.90e-03	206	200	6	EFO_0004612, EFO_0020947
Disease	cholesteryl esters to total lipids in small LDL percentage	APOB MAP4K5 LPA	2.90e-03	42	200	3	EFO_0022255
Disease	free cholesterol to total lipids in IDL percentage	APOC4 MAP4K5 LPA	3.10e-03	43	200	3	EFO_0022278
Disease	cholesteryl esters to total lipids in small HDL percentage	APOB MAP4K5 LPA	3.10e-03	43	200	3	EFO_0022254
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP2 HIVEP3	3.39e-03	13	200	2	DOID:0050787 (implicated_via_orthology)
Disease	apolipoprotein E measurement	APOC4 MAP4K5	3.39e-03	13	200	2	EFO_0008029
Disease	saturated fatty acids measurement	APOB MAP4K5 LPA	3.53e-03	45	200	3	EFO_0022304
Disease	Endogenous depression	ALB GNAS DRD5	3.76e-03	46	200	3	C0011573
Disease	triacylglycerol 52:1 measurement	SLC22A15 MAP4K5	3.94e-03	14	200	2	EFO_0010413
Disease	sulfate measurement	DNAI3 CADPS2	3.94e-03	14	200	2	EFO_0007864
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	APOB APOC4 ZNF106 MAP4K5 LPA	3.96e-03	153	200	5	EFO_0004611, EFO_0020946
Disease	phosphoglycerides measurement	APOC4 MAP4K5 LPA	4.24e-03	48	200	3	EFO_0022291
Disease	triacylglycerol 52:3 measurement	APOB MAP4K5	4.53e-03	15	200	2	EFO_0010415
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	APOB LPA	4.53e-03	15	200	2	EFO_0022328
Disease	response to statin, LDL cholesterol change measurement	APOB LPA	4.53e-03	15	200	2	EFO_0007804, GO_0036273
Disease	mammographic density measurement	GVINP1 TET3 ZNF365	4.76e-03	50	200	3	EFO_0005941
Disease	triglycerides to total lipids in medium LDL percentage	APOB MAP4K5 LPA	4.76e-03	50	200	3	EFO_0022334
Disease	polyunsaturated fatty acids to total fatty acids percentage	APOB MAP4K5 LPA	4.76e-03	50	200	3	EFO_0022303
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	DGKQ BANK1 BAZ1B APOB APOC4 MAP4K5 LPA	4.78e-03	303	200	7	EFO_0004612, EFO_0020945
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	BAZ1B APOB MAP4K5	5.03e-03	51	200	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	triglycerides to total lipids in large LDL percentage	APOB MAP4K5 LPA	5.03e-03	51	200	3	EFO_0022331
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	APOB MAP4K5 LPA	5.03e-03	51	200	3	EFO_0022302
Disease	cholesterol to total lipids in small HDL percentage	APOB MAP4K5 LPA	5.03e-03	51	200	3	EFO_0022240
Disease	cochlin measurement	G2E3 ZFPM2	5.15e-03	16	200	2	EFO_0801481
Disease	phospholipids in medium VLDL measurement	APOB APOC4 LPA	5.31e-03	52	200	3	EFO_0022154
Disease	Hypermetropia	ALMS1 KIF14 ARHGAP21 HIVEP3	5.37e-03	103	200	4	HP_0000540
Disease	ceramide measurement	STARD13 APOB ZMIZ1 APOC4 ZNF106 MAP4K5	5.49e-03	235	200	6	EFO_0010222
Disease	triglycerides to total lipids in very large VLDL percentage	APOB MAP4K5 LPA	5.60e-03	53	200	3	EFO_0022340
Disease	triglycerides in HDL measurement	APOB MAP4K5 LPA	5.60e-03	53	200	3	EFO_0022317
Disease	free cholesterol to total lipids in small LDL percentage	APOB MAP4K5 LPA	5.60e-03	53	200	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	APOB MAP4K5 LPA	5.60e-03	53	200	3	EFO_0022258
Disease	alpha-L-iduronidase measurement	DGKQ RNF212	5.81e-03	17	200	2	EFO_0020139
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB LPA	5.81e-03	17	200	2	EFO_0022232

Protein segments in the cluster

Peptide	Gene	Start	Entry
HLISSPLKKSRICDE	TTF1	61	Q15361
HSPKSVVTLLCGVKS	BANK1	106	Q8NDB2
CDLSIASKHISKPVQ	NAIP	436	Q13075
NCHFDPTISLKTVKL	BHMT	216	Q93088
DTALHQKKLCPLSLT	GNAS	91	P84996
TVKLKCKESDSPHAV	ERLEC1	431	Q96DZ1
LFSLSKRCHKQPLIS	BRINP3	376	Q76B58
TAHPKLCVSDLKTVT	BTNL3	296	Q6UXE8
LCVSDLKTVTHRKAP	BTNL3	301	Q6UXE8
AERITQLSAPHCKKL	ALDH8A1	236	Q9H2A2
SCPASKRKDVALLVT	CCR10	281	P46092
VLHEKTPVSDRVTKC	ALB	486	P02768
SKERKHLLSPDVSRC	CACNA1E	2086	Q15878
CSDVVVDHASKLKLP	B4GALNT1	476	Q00973
TAHPKLCVSDLKTVT	BTNL8	296	Q6UX41
LCVSDLKTVTHRKAP	BTNL8	301	Q6UX41
SIHLARKPNLGLKSC	BAZ1B	1031	Q9UIG0
KAKDDQTPLHCAARI	ANK1	466	P16157
KTKCIKSHLRSLLDP	GVINP1	586	Q7Z2Y8
KCLKTFRHKDPILAT	FBXW10	526	Q5XX13
CVHITLCPKTSSKLD	ALMS1	3046	Q8TCU4
SKEPSARLLKHVVRC	CNOT9	221	Q92600
KCSSTKHRIISPKVE	CAMTA2	241	O94983
SHEKCLKHVRIPCTS	DGKQ	96	P52824
KLLSRHRPTCETLEK	DNMBP	661	Q6XZF7
HAEDLASKLLQCSPK	CDK14	391	O94921
TSAAQLKLSPHLARC	DNHD1	2851	Q96M86
DSLLKKTHSLCPRLV	APOC4	106	P55056
KVRLSKGETSLDHCP	DNAI3	566	Q8IWG1
KGETSLDHCPTKISL	DNAI3	571	Q8IWG1
TKDLKSRSPHLDDCS	CASP8AP2	161	Q9UKL3
ACKNVTLHVPSKLDA	DSC2	31	Q02487
RPAKVNKAVTCAAHL	ARIH2OS	36	Q8N7S6
HLLSSPKESIRKEAC	KPNA5	346	O15131
KVCLTRDTIASHPKG	RASA4	86	O43374
LTECHRKSSAQGKPL	RANGAP1	166	P46060
CRATKKLLDNSHLPA	RAI1	1171	Q7Z5J4
DVVKPHLTSTKVASC	RAB38	191	P57729
KVCLTRDTIASHPKG	RASA4B	86	C9J798
SLSSITSLKKLCNHP	RAD54L	446	Q92698
SLQIKPCHSKSRGSI	RECK	416	O95980
AACAPDTSLRASIKK	DRD5	276	P21918
TKPSKSAALHIDLCK	INTS4	31	Q96HW7
TKTPSLAHLDTCLSK	IQCN	701	Q9H0B3
PKEKTRSEVICSIHF	PTPN3	21	P26045
PLLKSLVFSSHCKAV	INO80	966	Q9ULG1
CNKAFVTPSVLRSHK	PRDM5	466	Q9NQX1
LKIIEKACPSSDKHA	LTN1	716	O94822
KCLKTFRHKDPILAT	FBXW10B	526	O95170
GSLEKRTPTKCTTEH	KIF14	271	Q15058
LKKTLSRPGAVAHAC	OR1F12P	301	Q8NHA8
SCHVKRLEKRPSSTA	LIMD1	656	Q9UGP4
KTTTRGECPRKDSHL	ITPRID1	526	Q6ZRS4
LPSGLSDSKVLRHCK	MSS51	111	Q4VC12
KHSSKPIRVIDLSEC	GAB3	51	Q8WWW8
KCRKNHPDVASKLAT	GTSF1	36	Q8WW33
HKLLSRVAESCKPGA	ASMTL	536	O95671
SLPELTHALKTCFKV	DOP1B	521	Q9Y3R5
KADPCVAHALALRTA	LENG8	691	Q96PV6
LRSKPDRAQHAATKC	FICD	61	Q9BVA6
SKHLETSLTINKCVP	ZFPM2	796	Q8WW38
HGSSRCTDPKILKLS	PLXNA1	856	Q9UIW2
LKKTETPFGRCHSAV	MUC2	591	Q02817
SHSAVKSLCKTLRRP	NLRP1	821	Q9C000
PKKRAETIKFSHCAV	KCNJ15	171	Q99712
LCNLLVKDSKPHFTT	DPY19L1	646	Q2PZI1
TSQKLFHELCPVKRS	DNAJC16	366	Q9Y2G8
PKARVLRSKSLCHDE	CDC25B	366	P30305
CLSILTSHVKKTTPE	ELP1	836	O95163
VKDKDLNTPLHLACS	ANKRD44	901	Q8N8A2
DKPTTHEKTTKIACR	MKI67	1481	P46013
TTHEKTTKIACRSPQ	MKI67	2211	P46013
PFRQCKLTHALKDSL	KIF9	291	Q9HAQ2
FNKVDKHPDSTTLCL	HOPX	21	Q9BPY8
SREKTCDHLPKFLVI	NDST4	586	Q9H3R1
TLKTLKHPCIQRSAG	MROH8	351	Q9H579
CLNKKSPISHEESRL	PLCXD1	51	Q9NUJ7
DPISHSCVLLKSLDL	MAGEA13P	166	A6NCF6
DQPVLKLSCSSHFVK	OR1L1	231	Q8NH94
TCNPLSRKLHKILET	COG6	31	Q9Y2V7
CRKPKTSTDRHSLSL	FRMD6	531	Q96NE9
SILCHKPESLSAKIL	G2E3	581	Q7L622
SLVCPKDATRFKHLR	APOB	36	P04114
CKSEFPIRTLKTLLH	CKAP5	1751	Q14008
KIEVLHRPENCSKTS	FKBP7	36	Q9Y680
KSSLLSCVSHAKPAI	GTPBP10	161	A4D1E9
KCKRGETSLLHPRLS	GRHL3	561	Q8TE85
KEIRAHKVVLASCSP	KLHL17	101	Q6TDP4
RTHPDKITGCLSKLK	DOCK4	591	Q8N1I0
KPLHERLSSCFRELK	DOCK5	1616	Q9H7D0
RVEFPHKETLCSASK	C3P1	101	Q6ZMU1
LLHSHLSPENRCKKT	CPLANE1	2401	Q9H799
QPAISEKTDHKASCL	CDC7	486	O00311
HKIDCFISRPTEKTI	GJC1	216	P36383
PTLEPCSKAAKNRLH	GALNT8	566	Q9NY28
SVLFKTRLPHDKTKC	EXTL3	901	O43909
HSEPSRKIKECFKTS	C4orf17	111	Q53FE4
KRKTIAHSSSPCLVT	REXO1L1P	206	Q8IX06
CKQTLLKARHVAPSD	CTR9	736	Q6PD62
PKRSNHSKIIEDSDC	AKAP5	136	P24588
SIHTVTCKSPRQKED	CCDC57	786	Q2TAC2
VLTAAHCLKKSSRPS	LPA	1856	P08519
KASKTTDLRIPASVC	CADPS2	1066	Q86UW7
AALDKPAHKTESCLS	CEP162	566	Q5TB80
PAHKTESCLSTRKKS	CEP162	571	Q5TB80
SLGSKVKPISLADHC	KLK8	131	O60259
CSTKGTSKEPRHLQL	GRB10	321	Q13322
TCKFLTHKQLSPEDS	EME1	101	Q96AY2
HLKSLTPCTEKIRFS	E4F1	266	Q66K89
VFLTIPSLSHCKLDK	CCDC168	4566	Q8NDH2
TLIITPPSCKSHKSR	CCDC168	6851	Q8NDH2
SSHCPREAVIFKTKL	CCL7	56	P80098
CDTKPTLKRHIEFLD	GRK4	71	P32298
VCTHLQPSSKKSLSV	GRAMD2A	176	Q8IUY3
RNRKLKCTFSLTHPA	SLC22A15	271	Q8IZD6
LSVVHCNSRKDVKPE	PPHLN1	441	Q8NEY8
PTKAEEHRFQLTCKS	CFAP74	986	Q9C0B2
KIAHRSKRKLCPESS	C18orf63	631	Q68DL7
KASTIKHCPDSESRA	MAP4K5	411	Q9Y4K4
KLLGCSPALKRSHSD	CDC25A	111	P30304
KKCQDRSHLSISPVS	SYDE2	306	Q5VT97
DILPRLHKCLASTTK	UTP20	1786	O75691
SGKSRLTHICRIDLK	STARD13	1061	Q9Y3M8
KCNDSLRHSPKVETT	SMCHD1	1966	A6NHR9
SLAEHRTPDVLKKCQ	STIP1	326	P31948
KCGAIPKIHSARVSV	TMEM184B	271	Q9Y519
AALPHSCLERAKEIK	RGS5	6	O15539
CADSSKPTSTKIIHL	SAMD9	721	Q5K651
SPHKSLKCLAAETIA	ODAD2	546	Q5T2S8
LVALLDCAHDSTKPA	ODAD2	581	Q5T2S8
SARVAVKKIRCHAPE	PDIK1L	31	Q8N165
HCKKISSVGSALPRR	PIP4P2	176	Q8N4L2
LNRGHAIKIKSASPC	PTPN12	456	Q05209
PRTVSVRSSLKKHCN	SGO1	186	Q5FBB7
LKPCKAAELVATHFS	VPS8	971	Q8N3P4
VHTCKSKSTRNPLLK	WDR20	201	Q8TBZ3
LQSLAKKICSHSAPE	SURF6	11	O75683
FTPAKRLKNCHDTES	RNF220	136	Q5VTB9
SKSVAKLLHPQLACR	SPATA9	86	Q9BWV2
RSCLIHTSEKKAEIP	SLC39A6	301	Q13433
SLVKSASPEHTCVKS	ACSM1	201	Q08AH1
KALLDSHSIPTDCAK	CHAT	246	P28329
TSQRISCRPKTHISK	ZNF845	176	Q96IR2
TSQRKCKSPETALLH	PIK3CG	46	P48736
KAPCRTVLLSKHTDA	RNF212	46	Q495C1
LLSCPPHLLKSKSEA	PLEKHG5	866	O94827
IHLSCAKIRKSNVPE	PHF13	256	Q86YI8
KSSKVHLSENPFTCR	ZNF132	181	P52740
FTRPEHLGSSAKIKC	USP51	556	Q70EK9
LFKNKSCLTEPRRDH	ZNF586	96	Q9NXT0
LGLETHPRTAKTEKC	SETDB2	446	Q96T68
TGKCLKTLSAHSDPV	WDR5B	156	Q86VZ2
CPGLLSRHKTKKLSS	ZNF540	76	Q8NDQ6
RDSVKSCRVHVPEKT	ZNF671	226	Q8TAW3
RLVKEACTHNVASKP	ZNF804B	426	A4D1E1
SPKKCLESLAALRHA	ZFR2	761	Q9UPR6
KSKSPFAVCKHILET	XPO4	46	Q9C0E2
GHVLTDISSNRKPKC	ZNF365	306	Q70YC5
EKKSRARAQHIVPCT	RPA2	36	P15927
RHVQDPLAAAKKLCT	PHLPP2	1001	Q6ZVD8
VDPKNLCSKVSSRVH	SPEM3	81	A0A1B0GUW6
PNDSKHKRTDRSILC	PTGES3	61	Q15185
TDESCKKHLGRVLSI	RPRD1A	96	Q96P16
SHSPCLDSEAFQKRK	RYR3	1301	Q15413
KVLPKSHRELSQTFC	TSSK3	156	Q96PN8
RQRLKPAHSKLSSCV	ZNF592	271	Q92610
PAHSKLSSCVAALVA	ZNF592	276	Q92610
RSCLHIKRDKTLTGV	ZNF577	116	Q9BSK1
DKEACAHLLAITAPK	SPAG1	821	Q07617
HSRRCSKTLCKDSPE	SRRM4	221	A7MD48
ESCLDPTEHSLLNKK	WDR49	551	Q8IV35
CAKPSVLQKHIRSHT	HIVEP3	201	Q5T1R4
LCSKEFLNPVATKSH	ZNF646	1561	O15015
KRKPSSAKAHLDCDV	ZDBF2	616	Q9HCK1
RKEPNKSIKHCTVLS	TEX10	411	Q9NXF1
SPASKKCLTHLEDLQ	SENP6	221	Q9GZR1
NPNTLRLTKAHSCKL	TBCC	221	Q15814
HHPGTTKLTRKDCLA	TTLL2	146	Q9BWV7
TEKAPHKGIIRDSTC	PKHD1L1	3736	Q86WI1
ECARRELHATTPLKK	TET3	1666	O43151
KRTHKKLTINPCEIS	PSME4	1216	Q14997
TVTHKKAPSSLIDDC	TBC1D4	211	O60343
PTHLSCVKRKTTAAG	MAP2	1496	P11137
TLTDHKRIHTGEKPC	ZNF479	311	Q96JC4
CKSPKSTTAHAILRR	TSGA10	86	Q9BZW7
SCLTKHQRIHSSEKP	ZNF841	746	Q6ZN19
HTDFCNREKPLSTKS	ZNF598	831	Q86UK7
TLTIHKRIHTGEKPC	ZNF726	271	A6NNF4
KLAEHIRVHTKSCPA	ZNF786	746	Q8N393
VDSKPLKTLEDALHC	USP41	201	Q3LFD5
TTKLVPSIKRLHNCD	ZNF41	221	P51814
PSIKRLHNCDTILKH	ZNF41	226	P51814
LDHKRSTCPNIATSK	ZCCHC4	451	Q9H5U6
TCEKAFAKPSQLERH	ZNF236	1726	Q9UL36
VDSKPLKTLEDALHC	USP18	201	Q9UMW8
TKRAKIACNTHVAPR	TBCCD1	291	Q9NVR7
TAPRVLSSLKHLCRK	WSB2	361	Q9NYS7
RDCLKPSVLEKHIRS	ZNF831	151	Q5JPB2
CPQHSKRFLRALTKD	TRMT10B	101	Q6PF06
SIQIPEEDRCSHSKK	VEGFD	206	O43915
LKPLNAITCISEHSK	TUT7	641	Q5VYS8
RACAKPSVLKKHIRS	HIVEP2	196	P31629
HNKSPTLSCRFAILK	ARHGAP21	1511	Q5T5U3
ALNDVTAARKLKPCH	TTC4	136	O95801
KKPSTLLSCSRKLHN	UHRF1BP1	486	Q6BDS2
VPKTQHSKTLERFCS	ZFC3H1	1851	O60293
LRSSCPHVLKGNKST	ZNF106	506	Q9H2Y7
STDVSHCVKDRLPKC	SLFN5	201	Q08AF3
RNTVDVHTCKAPKKA	WNT2B	371	Q93097
HPSRVICKSGTSVKI	TRBV20-1	21	A0A075B6N2
PAEHCITKIKRNFSS	ZMIZ1	701	Q9ULJ6
KRLKLAASEDHCSPS	ZRANB3	576	Q5FWF4
ECKSHELKRGLSPVS	ZNF473	146	Q8WTR7
DCPKAFKRSSLLQIH	ZNF628	96	Q5EBL2
ETTHRKPCSEKVTDR	PP2D1	556	A8MPX8
KLTSELITHICKSLP	MX1	326	P20591
SLHGKKCTVSVETRL	MYO1D	971	O94832
PPHSLKCSEVRKDSL	MYOM1	1041	P52179
SPLCKAFRHVKVDTL	NECAB2	351	Q7Z6G3
HTPLDLTCSTKVKTL	NFKB2	731	Q00653